Sponsors (53)
The bill delivers a targeted $1.18 billion boost to DoD medical research and preserves ongoing projects and congressional priorities, at the expense of added federal spending, reduced DoD budget flexibility, and some administrative complications.
Researchers, hospitals, veterans, and military medical programs receive an additional ~$1.18 billion for Congressionally Directed Medical Research Programs, preserving ongoing studies, ensuring specified allocations, and aligning spending with the 2024 congressional priorities so research activities can continue and expand.
Taxpayers bear the roughly $1.18 billion increase in spending, which could contribute to the deficit or crowd out other federal priorities.
Specifying precise allocations and congressional priorities for these funds limits the Department of Defense's flexibility to reprogram or redirect funding in response to emergent military or public‑health needs.
The retroactive effective date may create administrative and budget‑accounting complications for the Defense Health Agency and the Secretary of Defense, requiring adjustments to obligations already executed under Public Law 119–4.
Based on analysis of 2 sections of legislative text.
Raises FY2025 appropriations total by $1,181,612,000 for DoD medical research and requires CDMRP funds to follow earlier explanatory-statement priorities.
Official title: To amend the Full-Year Continuing Appropriations and Extensions Act, 2025 to restore amounts available for Defense Health Agency research, development, test, and evaluation, including Congressionally Directed Medical Research Programs.
Introduced June 11, 2025 by André Carson · Last progress June 11, 2025
Increases the funding total for Congressionally Directed Medical Research Programs (CDMRP) in the FY2025 continuing appropriations measure by about $1.18 billion and requires those funds to be used consistent with prior explanatory guidance. The change is applied retroactively as if included in the original law, and the Department of Defense must obligate and expend the additional funds to preserve program continuity and follow the funding allocations and research priorities described in the cited explanatory statement. The amendment also trims language (removes the remainder of a sentence after the 23rd comma) in the original appropriation provision and directs the Secretary of Defense to implement the CDMRP funding consistent with the Consolidated Appropriations Act, 2024 explanatory statement guidance (pages 311–314), ensuring support for the named research programs, peer-reviewed initiatives, and projects.